Torrent Pharmaceuticals board to consider audited financial results

18 Jan 2013 Evaluate

Torrent Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on January 29, 2013, to consider and approve the audited financial results on standalone basis and unaudited financial results (with limited review) on consolidated basis of the company for the quarter and nine months ended on December 31, 2012 (Q3) and would also consider payment of interim dividend for the year 2012-13.

The above information is a part of company’s filings submitted to BSE

Torrent Pharma Share Price

3771.30 -21.35 (-0.56%)
30-Dec-2025 10:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1716.20
Dr. Reddys Lab 1270.50
Cipla 1487.20
Zydus Lifesciences 899.25
Lupin 2082.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×